Board Change • Jun 26
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. CEO, MD & Director Josh Mundey was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Sep 17
Visionflex Group Limited, Annual General Meeting, Nov 18, 2025 Visionflex Group Limited, Annual General Meeting, Nov 18, 2025. Annuncio • Jul 16
Visionflex Group Limited to Report Q4, 2025 Results on Jul 17, 2025 Visionflex Group Limited announced that they will report Q4, 2025 results on Jul 17, 2025 Annuncio • Feb 21
Visionflex Group Limited Announces Board Restructure, Effective March 1, 2025 Visionflex Group Limited announced a significant restructuring of Board of Directors, aimed at positioning company for continued success and growth. This restructure will become effective on 1st March 2025. Chris Whitehead, John Nantes, and Geoff Neate joined the Board at a critical time when the company was requiring a strategic transformation and capital restructure. At that time 1st Group (subsequently Visionflex) was subjected to a long-term trading halt due to a qualified audit. Their primary objective was to get the company relisted and restructure Visionflex for long-term growth. The Board has unanimously agreed that going forward the Board requires more intensive industry focus and guidance. Brook Adcock, the second-largest shareholder and DFA holder, will remain on the Board and assume the role of Interim Chairman. To ensure continuity and effective oversight, Josh Mundey will be promoted to Managing Director and join the Board, while Michael Kafrouni (Chief Operating Officer) will be promoted to Executive Director. The Board, now consisting of three members, will actively search for an independent director to align with the company's needs. Annuncio • Jan 30
Visionflex Group Limited to Report Q2, 2025 Results on Jan 30, 2025 Visionflex Group Limited announced that they will report Q2, 2025 results on Jan 30, 2025 Board Change • Dec 31
No independent directors There are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Non-Executive Director Brook Adcock is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Annuncio • Nov 14
Visionflex Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.75 million. Visionflex Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.75 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 437,500,000
Price\Range: AUD 0.004
Discount Per Security: AUD 0.00024
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Annuncio • Sep 23
Visionflex Group Limited, Annual General Meeting, Oct 24, 2024 Visionflex Group Limited, Annual General Meeting, Oct 24, 2024. Location: at the offices of automic, level 5, 126 phillip street, sydney nsw 2000., Australia Reported Earnings • Aug 30
Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in FY 2023) Full year 2024 results: AU$0.001 loss per share (improved from AU$0.002 loss in FY 2023). Revenue: AU$6.96m (up 56% from FY 2023). Net loss: AU$1.53m (loss narrowed 53% from FY 2023). Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings. New Risk • Jul 27
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 136% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-AU$7.0m). Shareholders have been substantially diluted in the past year (136% increase in shares outstanding). Market cap is less than US$10m (AU$13.4m market cap, or US$8.75m). Minor Risk Revenue is less than US$5m (AU$6.5m revenue, or US$4.2m). New Risk • Jul 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-AU$7.0m). Market cap is less than US$10m (AU$7.50m market cap, or US$5.06m). Minor Risks Shareholders have been diluted in the past year (5.9% increase in shares outstanding). Revenue is less than US$5m (AU$6.5m revenue, or US$4.4m). Board Change • Jun 05
No independent directors There are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Non-Executive Director Brook Adcock is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Annuncio • May 01
Visionflex Group Limited Announces Executive Changes Visionflex Group Limited announced that Ms Chelsea Sheridan of Automic Group has resigned as Company Secretary of the Company. Ms Sheridan will be replaced by Maria Clemente of Automic Group as Company Secretary effective immediately. Reported Earnings • Feb 28
First half 2024 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2023) First half 2024 results: AU$0.001 loss per share (improved from AU$0.003 loss in 1H 2023). Revenue: AU$4.01m (up 28% from 1H 2023). Net loss: AU$729.3k (loss narrowed 78% from 1H 2023). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings. Board Change • Jan 29
No independent directors There are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Non-Executive Director Brook Adcock is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Annuncio • Nov 15
Visionflex Group Limited Announces the Appointment of James Aulsebrook as Chief Financial Officer, Effective 14 February 2024 Visionflex Group Limited announced that it has appointed James Aulsebrook as its new Chief Financial Officer, effective from 14 February 2024. James is a Chartered Accountant with over 10 years’ experience leading and transforming financial operations in an ASX listed environment. For the past 7 years, he has served as the Chief Financial Officer of Jcurve Solutions Limited, during a period which saw multiple acquisitions and international expansion. Commencing his career as an auditor at PricewaterhouseCoopers, James is a former finalist in the prestigious CEO Magazine Awards, CFO of the Year award category and completed a Commerce/Science Degree at the University of New South Wales. Reported Earnings • Oct 05
Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.01 loss in FY 2022) Full year 2023 results: AU$0.002 loss per share (improved from AU$0.01 loss in FY 2022). Revenue: AU$4.47m (up 65% from FY 2022). Net loss: AU$3.28m (loss narrowed 39% from FY 2022). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Annuncio • Sep 26
1st Group Limited, Annual General Meeting, Oct 26, 2023 1st Group Limited, Annual General Meeting, Oct 26, 2023, at 09:00 AUS Eastern Standard Time. Location: The offices of Automic, Level 5, 126 Phillip Street, Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider Change of Company Name; to consider Election of Christopher Whitehead as a Director; to consider Election of Geoffrey Neate as a Director; to consider Re-election of John Nantes as Director; to consider ASX Listing Rule 7.1A Approval of Future Issue of Securities; to consider Adoption of 1st Group Omnibus Incentive Plan; to consider Consolidation of Capital; to consider Ratification of Prior Issue of Placement Shares under ASX Listing Rule 7.1; and to consider other matters. Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.013 loss in FY 2022) Full year 2023 results: AU$0.003 loss per share (improved from AU$0.013 loss in FY 2022). Revenue: AU$4.47m (down 12% from FY 2022). Net loss: AU$3.28m (loss narrowed 52% from FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings. Annuncio • Aug 22
1ST Group Limited Appoints Michael Kafruni as New Chief Operating Officer 1ST Group Limited advised that it has appointed Michael Kafruni as its new Chief Operating Officer, effective 21 August 2023. Michael is a qualified lawyer and has over 15 years' experience as a senior executive in multinational organizations in health, pharmaceutical, legal and accounting sectors including Althea Group Holdings Limited, CPA Australia Ltd. and DLA Piper LLC. Michael brings extensive multijurisdictional experience in commercial, operations, strategic partnerships and legal across startups and listed entities. Recruitment is underway for a new Chief Financial Officer, as part of a revamped leadership team focused on continued Australian expansion and international growth opportunities. Annuncio • Jul 01
Healthshare Pty Ltd. completed the acquisition of MyHealth1st from 1st Group Limited (ASX:1ST). Healthshare Pty Ltd. entered into a binding agreement to acquire MyHealth1st from 1st Group Limited (ASX:1ST) for AUD 1.3 million on April 21, 2023. The Transaction includes the sale of Assets, Client Agreements, Supplier Agreements, Intellectual Property, Goodwill, Business Names and Domain Names to HealthShare. The proceeds from the Transaction will provide further capital to support the ongoing growth of our diagnostic Telehealth product, Visionflex. Both parties have completed due diligence, with the completion of the Transaction not subject to any further material conditions. The transaction is expected to complete on May 31, 2023. As of June 22, 2023, the transaction is expected to complete on June 30, 2023.Healthshare Pty Ltd. completed the acquisition of MyHealth1st from 1st Group Limited (ASX:1ST) on June 30, 2023. The remaining portion of the purchase price (Final Payment) is payable in cash before August 31, 2023. Annuncio • May 06
1st Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.985453 million. 1st Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.985453 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 63,457,840
Price\Range: AUD 0.00765
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 65,359,541
Price\Range: AUD 0.00765
Transaction Features: Subsequent Direct Listing Board Change • Apr 26
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Geoff Neate was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Jan 26
1st Group Limited Appoints Joshua Mundey as Chief Executive Officer 1st Group Limited announced that it has appointed Joshua Mundey as its new permanent Chief Executive Officer, effective January 25, 2023. Mr. Mundey has been acting in the role of Interim CEO since October 2022. The decision to appoint Mr. Mundey in a permanent capacity has been taken by the Board as a direct result of his expressed commitment to the role, his exceptional professional track record and expertise, and the sustained focus that he has already brought to the executive leadership position. The Board have tasked Mr. Mundey with specific short term KPI's to address the following; Obtaining an unqualified auditors opinion as part of the current 1H financial audit requirements, Removing the ASX suspension, Continuing the improvement in the company's capital position and medium to longer term business performance. Joshua has over 15 years' experience in financial services and healthcare with an in-depth understanding of the Australian healthcare industry. Mr. Mundey has 15 years of healthcare and financial services experience working in organizations such as American Express, Investec Bank and most recently as the Co-Founder and Chief Growth officer of healthcare lender Credabl. Reported Earnings • Oct 05
Full year 2022 earnings released: AU$0.013 loss per share (vs AU$0.015 loss in FY 2021) Full year 2022 results: AU$0.013 loss per share. Revenue: AU$5.09m (down 6.6% from FY 2021). Net loss: AU$6.82m (loss widened 5.5% from FY 2021). Reported Earnings • Aug 31
Full year 2022 earnings released: AU$0.013 loss per share (vs AU$0.015 loss in FY 2021) Full year 2022 results: AU$0.013 loss per share. Revenue: AU$5.09m (down 6.6% from FY 2021). Net loss: AU$6.82m (loss widened 5.5% from FY 2021). Board Change • Apr 27
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Chairman Stephe Wilks is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Reported Earnings • Mar 06
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: AU$0.004 loss per share (vs AU$0.004 loss in 1H 2021). Revenue: AU$2.45m (down 5.9% from 1H 2021). Net loss: AU$1.94m (loss widened 8.2% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Board Change • Feb 23
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Chairman Stephe Wilks is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Board Change • Oct 19
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Chairman Stephe Wilks is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Reported Earnings • Sep 01
Full year 2021 earnings released: AU$0.015 loss per share (vs AU$0.013 loss in FY 2020) The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2021 results: Revenue: AU$5.45m (up 10.0% from FY 2020). Net loss: AU$6.47m (loss widened 29% from FY 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Executive Departure • Jun 10
Director Ross McCreath has left the company On the 2nd of June, Ross McCreath's tenure as Director ended after less than a year in the role. We don't have any record of a personal shareholding under Ross' name. A total of 6 executives have left over the last 12 months. The current median tenure of the management team is 1.83 years, which is considered inexperienced in the Simply Wall St Risk Model. Executive Departure • Jun 10
Company Secretary Andrew Whitten has left the company On the 3rd of June, Andrew Whitten's tenure as Company Secretary ended after 8.7 years in the role. We don't have any record of a personal shareholding under Andrew's name. A total of 6 executives have left over the last 12 months. The current median tenure of the management team is 1.83 years, which is considered inexperienced in the Simply Wall St Risk Model. Executive Departure • Jun 03
Independent Non-Executive Director Michael Emmett has left the company On the 25th of May, Michael Emmett's tenure as Independent Non-Executive Director ended after 2.4 years in the role. As of March 2021, Michael still personally held 7.04m shares (AU$169k worth at the time). A total of 4 executives have left over the last 12 months. The current median tenure of the management team is 1.83 years, which is considered inexperienced in the Simply Wall St Risk Model. Executive Departure • Jun 03
Independent Chairman of the Board Paul Welch has left the company On the 25th of May, Paul Welch's tenure as Independent Chairman of the Board ended after 3.2 years in the role. As of March 2021, Paul still personally held only 666.67k shares (AU$16k worth at the time). A total of 4 executives have left over the last 12 months. The current median tenure of the management team is 1.83 years, which is considered inexperienced in the Simply Wall St Risk Model. Executive Departure • Jun 03
Interim CEO & Director Louise McElvogue has left the company On the 25th of May, Louise McElvogue's tenure as Interim CEO & Director of the company ended after less than a year in the role. We don't have any record of a personal shareholding under Louise's name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is 1.83 years, which is considered inexperienced in the Simply Wall St Risk Model. Under Louise's leadership, the company delivered a total shareholder return of -20%. Reported Earnings • Oct 04
Full year earnings released - AU$0.013 loss per share Over the last 12 months the company has reported total losses of AU$5.01m, with losses widening by 16% from the prior year. Total revenue was AU$4.95m over the last 12 months, up 25% from the prior year. 